Alison Bauerlein

Gelesis, Inc. operates as a consumer-centered biotherapeutics company, which engages in the development of novel therapies to induce weight loss and metabolic disorders. Its commercial product portfolio includes Plenity, an FDA-cleared product to aid in weight management, as well as potential therapies in development for patients with Type 2 Diabetes, Non-alcoholic Fatty Liver Disease /Non-alcoholic Steatohepatitis, and Functional Constipation. The company was founded by Yishai Zohar in 2006 and is headquartered in Boston, MA.

Active Life Scientific, Inc. operates as a medical technology company that develops a device for measuring bone strength. Its BioDent is a reference point indenter for use in various applications that include lab and clinical research of bone fracture risk and effects of osteoporosis treatments and diagnosis and treatment of musculoskeletal diseases and disorders. The company was founded by Davis Brimer, Paul Hansma and Alexander Proctor in July 2007 and is headquartered in Santa Barbara, CA.

Equinox Ophthalmic, Inc. operates as a biotechnology company. It specializes in cataract, corneal and glaucoma surgery. The company was founded by John Berdahl and is headquartered in Sioux Falls, SD.

Koya Medical, Inc. is a privately held healthcare company founded in 2018 with the aim of transforming lymphatic and vein care through innovative patient-centric platforms. Koya Medical is based in Oakland, CA. The company is developing breakthrough treatments for venous diseases and lymphedema, and personalized care that is unavailable with traditional treatments. The company's first treatment, Dayspring, is a mobility-enabled active compression system that provides a treatment solution for lymphedema and CVI patients that won't interfere with their daily life. Anand Doraiswamy founded the company in 2018 and has been the CEO since then.